Vor Biopharma Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-10. The offering totals $110.1M, of which $110.1M was reported sold. Industry: Other.
| Name | Role | Location |
|---|---|---|
| Robert Ang | Director | Cambridge, MA |
| Sven Lundberg | Director | Cambridge, MA |
| Kush Parmar | Director | San Francisco, CA |
| Joshua Resnick | Director | New York, NY |
| Robert Ang | Executive Officer | Cambridge, MA |
| Nathan Jorgensen | Executive Officer | Cambridge, MA |
| Amy Mendel | Executive Officer | Cambridge, MA |